Alterity Therapeutics Limited
ATH
Clasificación en acciones
#26160
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Precio por acción
$0.18265392
Capitalización bursátil
$39.91M
Cambio (1 día)
1.96%
Cambio (1 año)
-47.81%
País
AU
Comercio Alterity Therapeutics Limited (ATH)
Categoría
Healthcare
Historial del precio de la acción de Alterity Therapeutics Limited (ATH)
Precio más alto de cierre: $0.33 el 2026-10-01
Precio más bajo de cierre: $13.50 el 2012-09-01
Precio más bajo de cierre: $13.50 el 2012-09-01
Historial del precio de la acción de Alterity Therapeutics Limited desde 2012 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | -12.13% |
| 2025 | 75.00% |
| 2024 | -18.18% |
| 2023 | -37.61% |
| 2022 | -59.70% |
| 2021 | -39.12% |
| 2020 | 63.99% |
| 2019 | -39.67% |
| 2018 | -32.87% |
| 2017 | 8.20% |
| 2016 | -48.69% |
| 2015 | -55.45% |
| 2014 | -69.99% |
| 2013 | 162.07% |
| 2012 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.17 | -4.24% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
